Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhen Qiu

Showing results (431-440 of 474) with videos related to

Pageof 48
Sort By:
Signal Transduction and Targeted Therapy|February 28, 2022
Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosisJin-Fei Lin, Pei-Shan Hu, Yi-Yu Wang, et al.
Nature Communications|November 17, 2022
First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumorsXiao-Li Wei, Fu-Rong Liu, Ji-Hong Liu, et al.
Cell Death & Disease|May 30, 2019
Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancerHong-En Yu, Feng Wang, Fang Yu, et al.
Frontiers in Pharmacology|December 31, 2025
Correction: Mitochondrial iron overload-mediated inhibition of Nrf2-HO-1/GPX4 assisted ALI-induced nephrotoxicityHui-Fang Deng, Lan-Xin Yue, Ning-Ning Wang, et al.
Cancer|May 30, 2025
Tebotelimab plus niraparib in previously treated locally advanced or metastatic solid tumors: A phase 1b dose escalation and expansion studyMiao-Zhen Qiu, Hongming Pan, Ka On Lam, et al.
World Journal of Gastroenterology|January 7, 2015
Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancerXiao-Li Wei, De-Shen Wang, Shao-Yan Xi, et al.
European Journal of Nutrition|September 23, 2025
Long-term cognitive benefits of human milk phospholipids in breastfed children at preschool age: results from MUAI studyMeng-Tao Yang, Qiu-Ye Lan, Che Pan, et al.
Cell Death & Disease|August 6, 2021
Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathwayFan Luo, Fei-Teng Lu, Miao-Zhen Qiu, et al.
Theranostics|March 21, 2018
XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem CellsJiao Ji, Yan Yu, Zhi-Ling Li, et al.
Chinese Medical Journal|December 30, 2015
China Patient-centered Evaluative Assessment of Cardiac Events Prospective Study of Acute Myocardial Infarction: Study DesignJing Li, Rachel P Dreyer, Xi Li, et al.
Pageof 48

Showing results (431-440 of 474) with videos related to

Sort By:
Pageof 48
Signal Transduction and Targeted Therapy|February 28, 2022
Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosisJin-Fei Lin, Pei-Shan Hu, Yi-Yu Wang, et al.
Nature Communications|November 17, 2022
First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumorsXiao-Li Wei, Fu-Rong Liu, Ji-Hong Liu, et al.
Cell Death & Disease|May 30, 2019
Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancerHong-En Yu, Feng Wang, Fang Yu, et al.
Frontiers in Pharmacology|December 31, 2025
Correction: Mitochondrial iron overload-mediated inhibition of Nrf2-HO-1/GPX4 assisted ALI-induced nephrotoxicityHui-Fang Deng, Lan-Xin Yue, Ning-Ning Wang, et al.
Cancer|May 30, 2025
Tebotelimab plus niraparib in previously treated locally advanced or metastatic solid tumors: A phase 1b dose escalation and expansion studyMiao-Zhen Qiu, Hongming Pan, Ka On Lam, et al.
World Journal of Gastroenterology|January 7, 2015
Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancerXiao-Li Wei, De-Shen Wang, Shao-Yan Xi, et al.
European Journal of Nutrition|September 23, 2025
Long-term cognitive benefits of human milk phospholipids in breastfed children at preschool age: results from MUAI studyMeng-Tao Yang, Qiu-Ye Lan, Che Pan, et al.
Cell Death & Disease|August 6, 2021
Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathwayFan Luo, Fei-Teng Lu, Miao-Zhen Qiu, et al.
Theranostics|March 21, 2018
XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem CellsJiao Ji, Yan Yu, Zhi-Ling Li, et al.
Chinese Medical Journal|December 30, 2015
China Patient-centered Evaluative Assessment of Cardiac Events Prospective Study of Acute Myocardial Infarction: Study DesignJing Li, Rachel P Dreyer, Xi Li, et al.
Pageof 48